Search terms
Results 31 - 40 of 91 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 10

Methods and results In 8592 subjects of the Prevention of Renal and Vascular End-stage Disease (PREVEND), a community-based, middle-aged cohort study, we performed cause-specific hazard analyses to ...

European Heart Journal, Brouwers, Frank P., de Boer, Rudolf A., van der Harst, Pim, Voors, Adriaan A., Gansevoort, Ron T., Bakker, Stephan J., Hillege, Hans L., van Veldhuisen, Dirk J., van Gilst, ...

Date : 14/05/2013 Item size : 289303 bytes

See page 2577 for the editorial comment on this article (doi:10.1093/eurheartj/ehq307) Introduction Erythropoietin (EPO) is commonly known as an effective treatment for anaemia, partly caused by an ...

European Heart Journal, Voors, Adriaan A., Belonje, Anne M.S., Zijlstra, Felix, Hillege, Hans L., Anker, Stefan D., Slart, Riemer H.J.A., Tio, René A., van ‘t Hof, Arnoud, Jukema, J. Wouter, ...

Date : 01/11/2010 Item size : 280692 bytes

Several controlled trials demonstrated that combination therapy can have additional benefits in hypertensive patients, in chronic heart failure patients, and in both diabetic and non-diabetic ...

European Heart Journal, van de Wal, Ruud M.A., van Veldhuisen, Dirk J., van Gilst, Wiek H., Voors, Adriaan A.

Date : 01/11/2005 Item size : 206620 bytes

Associations persisted after adjustment for demographics, risk factors for coronary artery disease, co-morbidity, Killip class, and baseline BDI score. See page 2607 for the editorial comment on ...

European Heart Journal, van Melle, Joost P., de Jonge, Peter, Ormel, Johan, Crijns, Harry J.G.M., van Veldhuisen, Dirk J., Honig, Adriaan, Schene, Aart H., van den Berg, Maarten P.

Date : 01/12/2005 Item size : 186545 bytes

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial.

European Heart Journal, van Veldhuisen, Dirk J., Crijns, Harry J.G.M., van den Berg, Maarten P.

Date : 01/01/2006 Item size : 84892 bytes

Digoxin in heart failure In the past, it was assumed that the beneficial effect of digoxin in HF was due to its (positive) inotropic properties, which were more pronounced at higher doses of the ...

European Heart Journal, van Veldhuisen, Dirk J., Van Gelder, Isabelle C., Ahmed, Ali, Gheorghiade, Mihai

Date : 21/05/2013 Item size : 162594 bytes

In partial AVSD, two separate orifices exist with distinguishable right and left AV-valves, whereas patients with complete AVSD have a common AV-orifice.1 The majority of AVSD patients reach ...

European Heart Journal, Drenthen, Willem, Pieper, Petronella G., van der Tuuk, Karin, Roos-Hesselink, Jolien W., Voors, Adriaan A., Mostert, Bianca, Mulder, Barbara J.M., Moons, Philip, Ebels, Tjark, ...

Date : 01/12/2005

Methods and results CONFIRM-HF was a multi-centre, double-blind, placebo-controlled trial that enrolled 304 ambulatory symptomatic HF patients with left ventricular ejection fraction 45%, elevated ...

European Heart Journal, Ponikowski, Piotr, van Veldhuisen, Dirk J., Comin-Colet, Josep, Ertl, Georg, Komajda, Michel, Mareev, Viacheslav, McDonagh, Theresa, Parkhomenko, Alexander, Tavazzi, Luigi, ...

Date : 14/03/2015 Item size : 331089 bytes

5 ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  .  Effects of moderate or intensive disease management program on outcome in patients with heart failure.

European Heart Journal, Jaarsma, Tiny, Lesman, Ivonne, van Veldhuisen, Dirk J.

Date : 01/05/2008

In this landmark trial patients with systolic heart failure in New York Heart Association (NYHA) class III were included. [...]patients with potassium levels >5 mmol/L were excluded from ...

European Heart Journal, van der Meer, Peter, van Veldhuisen, Dirk J.

Date : 01/04/2011